MS
Satellos Bioscience Inc.
MSCL.TO · TSX
$13.20 -5.24% (-$0.73)
1M -1.35%
Market Cap $209.7M
P/E Ratio -
Div. Yield -
ROE 71.28%
Bulios Fair Price
$10.3
22.0% downside
Trenutna cena
$13.2
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MSCL.TO trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
58 /100
Fair P/B 3.51x
P/E N/A
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 101.91%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 59.83%
Asset turnover 0.00x
ROE 71.28%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 11.22x
Int. coverage N/A
Stability
46 /100
Moderate Beta 1.14x
Profitable years 0
EPS volatility 43.08%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MSCL.TO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Francis Gleeson
Employees
18
Headquarters
Toronto
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report